Neuroendocrine breast tumors represent a rare subtype of breast cancer, accounting for less than 1% of all neuroendocrine neoplasms. Starting from their pathology definition, and going through their prevalence, prognosis and treatment, our knowledge is still really uncertain. In the present short review of the medical literature on this topic, we have evaluated in details their epidemiology, risk factors, pathogenesis, pathology, clinical presentation, radiographic aspects, prognosis, and therapy. We have thus been able to identify a number of open issues regarding primary neuroendocrine neoplasms of the breast that need to be clarified. Our ultimate aim was actually to try to understand whether neuroendocrine neoplasms of the breast can be considered a definite clinical entity and if neuroendocrine differentiation of breast tumors has a really clinical relevance.
Primary neuroendocrine neoplasms of the breast: still open issues / Gallo, Marco; Campione, Severo; Di Vito, Valentina; Fortunati, Nicoletta; Lo Calzo, Fabio; Messina, Erika; Ruggeri, Rosaria Maddalena; Faggiano, Antongiulio; Colao, Annamaria Anita Livia. - In: FRONTIERS IN ENDOCRINOLOGY. - ISSN 1664-2392. - 11:(2021). [10.3389/fendo.2020.610230]
Primary neuroendocrine neoplasms of the breast: still open issues
Gallo, Marco
;Di Vito, Valentina;Faggiano, Antongiulio;
2021
Abstract
Neuroendocrine breast tumors represent a rare subtype of breast cancer, accounting for less than 1% of all neuroendocrine neoplasms. Starting from their pathology definition, and going through their prevalence, prognosis and treatment, our knowledge is still really uncertain. In the present short review of the medical literature on this topic, we have evaluated in details their epidemiology, risk factors, pathogenesis, pathology, clinical presentation, radiographic aspects, prognosis, and therapy. We have thus been able to identify a number of open issues regarding primary neuroendocrine neoplasms of the breast that need to be clarified. Our ultimate aim was actually to try to understand whether neuroendocrine neoplasms of the breast can be considered a definite clinical entity and if neuroendocrine differentiation of breast tumors has a really clinical relevance.File | Dimensione | Formato | |
---|---|---|---|
Gallo_Primary-Neuroendocrine_2021.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
391.82 kB
Formato
Adobe PDF
|
391.82 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.